Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.30

€0.30

8.370%
0.0265
8.370%
€1.00

€1.00

 
23.06.21 / Tradegate WKN: A2P082 / Name: Mountain Valley MD Holdings / Stock / Metals & Mining / Micro Cap /
Latest predictions
€1.00
24.02.21
-71.21%
buy
€1.00
17.02.21
-78.20%
buy
€1.00
08.08.20
56.05%
buy
Your prediction

Mountain Valley MD Holdings Inc. Stock

Mountain Valley MD Holdings Inc. dominated the market today, gaining €0.027 (8.370%).
Currently there is a rather positive sentiment for Mountain Valley MD Holdings Inc. with 3 Buy predictions and 0 Sell predictions.
Based on the current price of €0.30 the target price of €1.00 shows a potential of 237.268% for Mountain Valley MD Holdings Inc. which would more than double the current price.

Pros and Cons of Mountain Valley MD Holdings Inc. in the next few years

Pros
?
Brand
?
Conscious of the environment
?
Worthwhile Investment for the next years
Cons
?
Shareholder structure
?
Market Position
?
Growth compared to competition
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Mountain Valley MD Holdings Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Mountain Valley MD Holdings Inc. 8.370% -6.319% -26.152% -48.524% -11.756% -48.524% -85.293%
Rockhaven Resources Ltd - 0.000% 0.000% 24.088% -7.104% 21.429% -20.561%
Vior Inc. 3.170% 5.691% 9.244% 108.000% 63.522% 136.364% 165.306%
Copper Fox Metals Inc. -4.000% -13.174% -30.622% 342.748% -1.361% 468.627% 222.222%

Other discussions about Mountain Valley MD Holdings Inc. Stock

New thread Forum

News

Mountain Valley MD Commencing Trials in Bangladesh, Striking Pharmaceutical Production Agreements: https://www.irw-press.at/prcom/images/messages/2021/57310/PR2021-03-16-MVMD_PRcom.001.png
Mountain Valley MD Commencing Trials in Bangladesh, Striking Pharmaceutical Production Agreements

 

TORONTO, ON - March 16, 2021 - Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA:20MP) (OTCQB: MVMDF) is pleased to announce it is commencing husbandry animal

Mountain Valley MD Achieves Solubilization of Selamectin, Files Trademark For Selactosol™: https://www.irw-press.at/prcom/images/messages/2021/57204/MVMD_031021_ENPRcom.001.png
Mountain Valley MD Achieves Solubilization of Selamectin, Files Trademark For Selactosol™

TORONTO, ONMarch 10, 2021 - Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA:20MP) (OTCQB: MVMDF) is pleased to announce it has achieved a water solubilized

Mountain Valley MD Proceeding with FDA 505(b)(2) Pathway Application for Novel Ivectosol™

-          And provides update on its BSL-4 and Dose Sparing Adjuvant Trials

 

TORONTO, ONMarch 3, 2021 - Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA:20MP)